De la maculopathie à la dégénérescence maculaire liée à l’âge : modalités de suivi et de traitement

Bunce, 2008, Causes of blind certifications in England and Wales: April 1999–March 2000, Eye (Lond), 22, 905, 10.1038/sj.eye.6702767 World Health Organization, 2002 Rudnicka, 2012, Age and gender variations in age-related macular degeneration prevalence in populations of European ancestry: a meta-analysis, Ophthalmology, 119, 571, 10.1016/j.ophtha.2011.09.027 Delcourt, 2005, The three-year incidence of age-related macular degeneration: the “Pathologies Oculaires Liées à l’Age” (POLA) prospective study, Am J Ophthalmol, 140, 924, 10.1016/j.ajo.2005.05.002 Haines, 2005, Complement factor H variant increases the risk of age-related macular degeneration, Science, 308, 419, 10.1126/science.1110359 Edwards, 2005, Complement factor H polymorphism and age-related macular degeneration, Science, 308, 421, 10.1126/science.1110189 Klein, 2005, Complement factor H polymorphism in age-related macular degeneration, Science, 308, 385, 10.1126/science.1109557 Mitchell, 1998, Iris color, skin sun sensitivity, and age-related maculopathy. The Blue Mountains Eye Study, Ophthalmology, 105, 1359, 10.1016/S0161-6420(98)98013-7 Khan, 2006, Smoking and age related macular degeneration: the number of pack years of cigarette smoking is a major determinant of risk for both geographic atrophy and choroidal neovascularisation, Br J Ophthalmol, 90, 75, 10.1136/bjo.2005.073643 Delcourt, 1998, Smoking and age-related macular degeneration. The POLA Study. Pathologies oculaires liées à l’âge, Arch Ophthalmol, 116, 1031, 10.1001/archopht.116.8.1031 Maralani, 2015, Metabolic syndrome and risk of age-related macular degeneration, Retina, 35, 459, 10.1097/IAE.0000000000000338 Clemons, 2005, Risk factors for the incidence of Advanced Age-Related Macular Degeneration in the Age-Related Eye Disease Study (AREDS) AREDS report no. 19, Ophthalmology, 112, 533, 10.1016/j.ophtha.2004.10.047 Delcourt, 1999, Age-related macular degeneration and antioxidant status in the POLA study. POLA Study Group. Pathologies oculaires liées à l’âge, Arch Ophthalmol, 117, 1384, 10.1001/archopht.117.10.1384 Sangiovanni, 2007, The relationship of dietary carotenoid and vitamin A, E, and C intake with age-related macular degeneration in a case-control study: AREDS Report No. 22, Arch Ophthalmol, 125, 1225, 10.1001/archopht.125.9.1225 Tan, 2008, Dietary antioxidants and the long-term incidence of age-related macular degeneration: the Blue Mountains Eye Study, Ophthalmology, 115, 334, 10.1016/j.ophtha.2007.03.083 2001, A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8, Arch Ophthalmol, 119, 1417, 10.1001/archopht.119.10.1417 Chen, 2015, Bevacizumab versus ranibizumab for neovascular age-related macular degeneration: a meta-analysis of randomized controlled trials, Retina, 35, 187, 10.1097/IAE.0000000000000301 Wang, 2014, Systemic adverse events after intravitreal bevacizumab versus ranibizumab for age-related macular degeneration: a meta-analysis, PLoS One, 9, e109744, 10.1371/journal.pone.0109744 Moja, 2014, Systemic safety of bevacizumab versus ranibizumab for neovascular age-related macular degeneration, Cochrane Database Syst Rev, 9, CD011230 Campbell, 2014, Adverse gastrointestinal events with intravitreal injection of vascular endothelial growth factor inhibitors: nested case-control study, Drug Saf, 37, 723, 10.1007/s40264-014-0211-6 Nguyen, 2015, Conbercept (KH-902) for the treatment of neovascular age-related macular degeneration, Expert Rev Clin Pharmacol, 8, 541, 10.1586/17512433.2015.1075879 Tolentino, 2015, Drugs in Phase II clinical trials for the treatment of age-related macular degeneration, Expert Opin Investig Drugs, 24, 183, 10.1517/13543784.2015.961601 Wong, 2015, Polypoidal choroidal vasculopathy in Asians, J Clin Med, 4, 782, 10.3390/jcm4050782 Soubrane, 2007, Dégénérescence maculaire liée à l’âge. Formes cliniques, 350 Kauffmann, 2014, Relation entre injection intra-vitréenne d’anti-VEGF et hématome sous-rétinien chez des patients atteints d’une dégénérescence maculaire liée à l’âge exsudative, J Fr Ophtalmol, 37, 195, 10.1016/j.jfo.2013.08.005 Avery, 1996, Natural history of subfoveal subretinal hemorrhage in age-related macular degeneration, Retina, 16, 183, 10.1097/00006982-199616030-00001 Glatt, 1982, Experimental subretinal hemorrhage in rabbits, Am J Ophthalmol, 94, 762, 10.1016/0002-9394(82)90301-4 Haupert, 2001, Pars plana vitrectomy, subretinal injection of tissue plasminogen activator, and fluid-gas exchange for displacement of thick submacular hemorrhage in age-related macular degeneration, Am J Ophthalmol, 131, 208, 10.1016/S0002-9394(00)00734-0 Auriol, 2010, Traitement des hématomes maculaires compliquant la DMLA par vitrectomie, injection sous-rétinienne de rt-PA et tamponnement intra-oculaire par gaz, J Fr Ophtalmol, 33, 84, 10.1016/j.jfo.2009.12.005 Daien, 2014, Visual acuity thresholds associated with activity limitations in the elderly. The Pathologies Oculaires liées à l’Age study, Acta Ophthalmol, 92, e500, 10.1111/aos.12335 Kulmala, 2008, Lowered vision as a risk factor for injurious accidents in older people, Aging Clin Exp Res, 20, 25, 10.1007/BF03324744 Knudtson, 2009, Biomarkers of aging and falling: the Beaver Dam eye study, Arch Gerontol Geriatr, 49, 22, 10.1016/j.archger.2008.04.006 Vu, 2005, Impact of unilateral and bilateral vision loss on quality of life, Br J Ophthalmol, 89, 360, 10.1136/bjo.2004.047498 Anand, 2003, Postural stability in the elderly during sensory perturbations and dual tasking: the influence of refractive blur, Invest Ophthalmol Vis Sci, 44, 2885, 10.1167/iovs.02-1031 Evans, 2007, Depression and anxiety in visually impaired older people, Ophthalmology, 114, 283, 10.1016/j.ophtha.2006.10.006